VOLUME 32, NUMBER 10 THURSDAY, October 26, 2000
ReporterFront_Page

Kapoor gives $5 million to Pharmacy
Alumnus' gift to strengthen school's research core, create instrumentation center

send this article to a friend

By SUZANNE CHAMBERLAIN
Reporter Contributor

Venture strategist and scientist John N. Kapoor-founder, chairman and CEO of E.J. Financial Enterprises, Inc.-has given $5 million to UB.

Kapoor's generosity will help strengthen the School of Pharmacy and Pharmaceutical Sciences' research core, provide resources to create a state-of-the-art instrumentation center and fortify the pharmaceutical-science faculty.
Kapoor

The gift will be given over a period of five years and is considered a leadership gift in UB's $250 million campaign-the university's first national-international campaign, the first university-wide campaign and the first to be alumni-driven, with campaign volunteer leaders from all over the country. It is the largest gift ever given to the School of Pharmacy and Pharmaceutical Sciences.

Born in 1943 in India, Kapoor received his undergraduate degree in pharmacy from Bombay University and dreamed of coming to the United States for graduate work. Financial support from UB enabled him to earn his doctorate from the School of Pharmacy and Pharmaceutical Sciences in 1972.

"I've got a very strong attachment with the school and I've stayed in touch with everyone, especially Jere Solo and Wayne Anderson. I feel like they have excellent ideas to build the school and take it into the new millennium, and if I can do anything to help that I feel honored," Kapoor said.

President William R. Greiner praised Kapoor for his talent and his support of the university and the School of Pharmacy and Pharmaceutical Sciences.

"John Kapoor is a brilliant entrepreneur and visionary leader in the pharmaceutical industry. Boldness, creativity and innovation have characterized his leadership of Lyphomed Inc. and E.J. Financial Enterprises; he is a wonderful role model for today's UB students," Greiner noted. "He has demonstrated an unswerving loyalty to his alma mater over the years, as evidenced by his latest gift to UB. We are extremely grateful to Dr. Kapoor for his generosity, which will enhance pharmaceutical research and augment our pharmaceutical-science faculty."

Kapoor's philanthropy will position UB scientists to continue a research focus in rapidly developing research areas that will benefit human health.

"The School of Pharmacy and Pharmaceutical Sciences has developed a strong reputation of excellence, noted Dean Wayne K. Anderson. "It has a strong faculty and attracts a group of very good students.

"Nevertheless, we face a continuing challenge to build upon our strengths in the fast-paced environment of scientific and technological growth. This gift enables the school to move forward with its goals in education and research, and to continue to set new standards for excellence," Anderson said.

Kapoor began his corporate career on Grand Island as general manager for Lyphomed, a unit of Stone Container Corp. He was named president of the division in 1980, and in 1981 he bought the company for $2.7 millionóbecoming chairman, president and CEO, and renaming the firm Lyphomed Inc.

During his years managing Lyphomed, Kapoor increased sales to $172 million from $4 million. He sold Lyphomed and used $40 million of the profits to form E.J. Financial Enterprises Inc., which invests in health-care startups.

E.J. Financial Enterprises is invested in at least two dozen companies whose products range from opthalmics to experimental gene therapies for cancer and AIDS. Among these are Option Care Inc., the nationís largest publicly traded franchiser of home health-care and drug-therapy services; Structural Bioinformatics Inc., which uses gene-sequence data for drug discovery and design process, and Tech India Ventures Inc., in his native India, a pharmaceutical marketing and distribution company.

Kapoor also is a partner in the Texas Biomedical Development Partners (TBDP), formed to provide funding and commercialization resources for selected biomedical technologies within the University of Texas System.

In 1987, he established the John Kapoor Graduate Fellowship in Medicinal Chemistry Fund in the School of Pharmacy and Pharmaceutical Sciences, and received the UB Distinguished Alumnus Award. He was awarded a SUNY honorary doctorate in science during UBís commencement last May.

Front Page | Top Stories | Photos | Briefly | Q&A | Electronic Highways
Sports | The Mail | Transitions | Events | Current Issue | Comments?
Archives | Search | UB Home | UB News Services | UB Today